You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
康德萊醫械(01501.HK):上限定價淨籌7.58億港元 公開發售大幅超購267倍
格隆匯 11-07 11:11

格隆匯11月7日丨康德萊醫械(01501.HK)公佈,公司全球發售4000萬股,其中國際發售2000萬股佔50%,香港發售2000萬股佔50%;每股定價20.80港元,為招股價範圍(20.10港元至20.80港元)上限,集資淨額7.58億港元;1手中籤率30.00%;預計11月8日掛牌。

公開發售合共接獲約4.21萬份有效申請,認購合共約10.72億股公開發售股份,相當於公開發售項下初步可供認購香港發售股份總數400萬股的約267.97倍。國際發售項下初步提呈發售的發售股份已獲超額認購國際發售項下初步可供認購國際發售股份總數3600萬股的約9.6倍。

基石投資者方面,OrbiMed Partners Master Fund Limited;及Worldwide HealthcareTrust PLC均已分別認購388.44萬股發售股份及742.84萬股發售股份,總計1131.28萬股發售股份,合共佔緊隨全球發售完成後公司已發行股本總額的約7.07%;及全球發售項下發售股份數目的約28.28%,在兩種情況下均假設超額配股權未獲行使。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account